Dicerna Pharmaceuticals, Inc. DRNA
38.22 +38.22
Quote time unavailable
Day range unavailable
52-week range unavailable
DRNA revenue history
Revenue is income from the company’s ordinary business activities.
164,307,000 USD
FY 2020 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2020 | 2020-12-31 | 164,307,000 | 140,403,000 | 587.36% |
| FY 2019 | 2019-12-31 | 23,904,000 | 17,728,000 | 287.05% |
| FY 2018 | 2018-12-31 | 6,176,000 | 5,146,000 | 499.61% |
| FY 2017 | 2017-12-31 | 1,030,000 | 1,030,000 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | -184,000 | -100.00% |
| FY 2015 | 2015-12-31 | 184,000 | 184,000 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | -7,015,000 | -100.00% |
| FY 2012 | 2012-12-31 | 7,015,000 | -893,000 | -11.29% |
| FY 2011 | 2011-12-31 | 7,908,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:05.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.